Daily news email for July 19, 2012 | Click here for updated news
Biotechnology - Moreover Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)
NIH Translational Center Should Raise All Boats, BIO Says
Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update
Biotechnology to be 21st-century industry: Life Tech CEO
|
Burrill Report Senator Turns Heat Up on FDA in Spying Scandal
Vivus Obesity Drug Gains FDA Approval
Senator Says FDA Spying on Whistleblowers was Authorized
AstraZeneca Ramping up Virtual Neuroscience Effort
Chelsea Therapeutics' CEO Steps Down
|
CenterWatch - Clinical Trials Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend
New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising
Technology companies adapt interactive video concepts for clinical trial informed consent
CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases
New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
|
Sports News - ESPN Saban: Tax Penn State athletics to benefit kids
Penn St. trustees chair vows changes will occur
Report: TCU settles suit from Big East for $5M
Report: Big East drops lawsuit filed against TCU
Pitt to pay $7.5M to leave Big East in July 2013
|
Xconomy Life Sciences From One Japanese Backer to Another: Galenea Advances Brain Drugs
San Diego Life Sciences Roundup: Life, BioSurplus, Obalon, & More
Biotech VCs, in Shadow of Tech, Start Delivering More Hits
NanoString Makes IPO Prep Move, Adds Finance Vet to Board
Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day
|
Yahoo Biotech News Slow, costly process stymies generic biotech drugs
(Reuters)
Analysis: Slow, costly process stymies generic biotech drugs
(Reuters)
Waves Break Coral Embryo into Identical Twins
(LiveScience.com)
Autoinjector Version of MS Drug Approved
(HealthDay)
Fake Avastin had salt, starch, chemicals: Roche
(Reuters)
|